
Karis Bio
Developer of cell therapy designed to treat cardiovascular disease. The company develops cell-based therapy for treating patients with cardiovascular diseases using patented clinically applicable Indu...
Valuation
$0
Share Price
N/A
Total Raised
$95.3M
Last Round
N/A